According to the new notification issued by the
Ministry Of Health And Family Welfare on Tuesday (February 11, 2020), all the medical devices sold in the country will be considered as drugs and be regulated under the
Drugs and Cosmetics Act, 1940 from the next financial year starting in April, 2020. According to the current law only 23 medical devices are categorised as drugs. These include cardiac stents, drug eluting, condoms, intrauterine device; among other devices which have been brought under price control.
This decision was taken by the health ministry after due consultation with the Drugs Technical Advisory Board (DTAB) which is considered as the supreme decision making body on technical matters related to drugs. The health ministry also introduced some amendments to the
Medical Devices Rules, 2017 (which was made public and suggestions were invited from stakeholders). Now it will be called the
Medical Devices (Amendment) Rules, 2020 from 1st of April, 2020. The amendment says that all the medical devices should be registered with the Central Licensing Authority through an identified online portal established by the
Central Drugs Standard Control Organisation (CDSCO). This registration is voluntary but after 18 months, it’ll be mandatory for everyone.
The manufacturer and importers of a medical device should upload all the information related to that device for getting the registration done on “Online System for Medical Devices” established by the CDSCO. The notification issued by the health ministry says,
"Central Licensing Authority may verify the documents at any point of time and investigate quality or safety related failure or complaints." The license of manufacturer can also be cancelled if found lapsed. It also provides a timeline for the registration of devices. It gives the period of 30 months from date of commencement of the rules to low and moderate risk devices and 42 months to moderate high risk and high risk devices within which it will be brought per the new regulations. Malini Aisola from healthcare activist group, All India Drug Action Network's (AIDAN) said that
"Registration requirements for all devices is positive. Timeline for subjecting devices that will be duly notified as of April 1, ranges from 2.5 years to 3.5 years.So India has a loooongg wait before all its higher risk devices are regulated." The industry lobby said that there is no gurantee that MoH will work with NITI Aayog on the draft Medical Devices Bill. Rajiv Nath of Association of Indian Medical Device Industry (AIMED) said
that “We are highly uncomfortable to be regulated under the very rigid and prescriptive Drugs Act as any non-conformity can be treated as a criminal offence by any Drug Inspector at his discretion and hauled before a court and there are no risk proportionate penalties." Author - Aditi Dubey
Patient Awarded Rs.1.6 Lakh Compensation for Botched Surgery
A resident of Chennai New Washermenpet, Jhansi Rani filed a complaint against a hospital in Tondiarpet, Chennai where she underwent a sterilization surgery in 2001. In her complaint, she mentioned that after her surgery she led a normal life but sometimes felt abdominal pain and vomiting. She continued this way until 2017 when one day she fainted due to her unbearable pain. She was admitted to Government Stanley Hospital where the doctors informed that her life was in danger and they need...
Primary Issues About The National Medical Commission Act, 2019
Executive
Sep 30, 2020
Rhea Banerjee
(
Editor: Ekta Joshi
)
7 Shares
The National Medical Commission Act, 2019 is a significant reform brought in the field of medical education, and the Act received its assent from the President on 8th August 2019 and it came into force on 25th September 2020. The main purpose of the Act was to bring in positive changes in the field of medical sciences as well as in the medical education system in order to enhance the quality of medical studies and make it affordable to more students. The legislation regulating before NMC...
Facebook Comments